Top 50 Global Pharmaceutical Brands Ranked by Value, Featuring 10 Chinese Companies

Deep News

May 19

The UK-based brand valuation consultancy Brand Finance has released its "Healthcare 2026" report, which includes the "Top 50 most valuable Pharma brands" ranking for 2026. Johnson & Johnson, Eli Lilly, and Roche secured the top three positions. Notably, ten Chinese brands made the list: Sinopharm, Guangzhou Pharmaceuticals, SPH (Shanghai Pharmaceuticals), Yunnan Baiyao, Huadong Medicine, 999 (China Resources Sanjiu), Tong Ren Tang (Beijing Tongrentang), CSPC Pharma, Fosun Pharma, and Pien Tze Huang. Brand value is defined as the net economic benefit a brand owner would receive from licensing the brand in an open market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1194976561"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194976561\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194976561?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-19 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194976561","market":"hk","top_or_hot":-1,"title":"Top 50 Global Pharmaceutical Brands Ranked by Value, Featuring 10 Chinese Companies","media":"Deep News","content":"<p>The UK-based brand valuation consultancy Brand Finance has released its \"Healthcare 2026\" report, which includes the \"Top 50 most valuable Pharma brands\" ranking for 2026. Johnson & Johnson, Eli Lilly, and Roche secured the top three positions. Notably, ten Chinese brands made the list: Sinopharm, Guangzhou Pharmaceuticals, SPH (Shanghai Pharmaceuticals), Yunnan Baiyao, Huadong Medicine, 999 (China Resources Sanjiu), Tong Ren Tang (Beijing Tongrentang), CSPC Pharma, Fosun Pharma, and Pien Tze Huang. Brand value is defined as the net economic benefit a brand owner would receive from licensing the brand in an open market.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top 50 Global Pharmaceutical Brands Ranked by Value, Featuring 10 Chinese Companies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop 50 Global Pharmaceutical Brands Ranked by Value, Featuring 10 Chinese Companies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-05-19 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The UK-based brand valuation consultancy Brand Finance has released its \"Healthcare 2026\" report, which includes the \"Top 50 most valuable Pharma brands\" ranking for 2026. Johnson & Johnson, Eli Lilly, and Roche secured the top three positions. Notably, ten Chinese brands made the list: Sinopharm, Guangzhou Pharmaceuticals, SPH (Shanghai Pharmaceuticals), Yunnan Baiyao, Huadong Medicine, 999 (China Resources Sanjiu), Tong Ren Tang (Beijing Tongrentang), CSPC Pharma, Fosun Pharma, and Pien Tze Huang. Brand value is defined as the net economic benefit a brand owner would receive from licensing the brand in an open market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1194976561","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194976561","pubTimestamp":1779192139,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"The UK-based brand valuation consultancy Brand Finance has released its \"Healthcare 2026\" report, which includes the \"Top 50 most valuable Pharma brands\" ranking for 2026. Johnson & Johnson, Eli...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1574":"生物医药B类股","01477":"欧康维视生物-B","BK1191":"制药"},"translate_title":"全球医药品牌价值排名50强，中国企业10家","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01477":1},"content_text":"The UK-based brand valuation consultancy Brand Finance has released its \"Healthcare 2026\" report, which includes the \"Top 50 most valuable Pharma brands\" ranking for 2026. Johnson & Johnson, Eli Lilly, and Roche secured the top three positions. Notably, ten Chinese brands made the list: Sinopharm, Guangzhou Pharmaceuticals, SPH (Shanghai Pharmaceuticals), Yunnan Baiyao, Huadong Medicine, 999 (China Resources Sanjiu), Tong Ren Tang (Beijing Tongrentang), CSPC Pharma, Fosun Pharma, and Pien Tze Huang. Brand value is defined as the net economic benefit a brand owner would receive from licensing the brand in an open market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}